The National Pharmaceutical Pricing Authority (NPPA) has released price listing of 631 medical devices, which falls under the five medical devices it capped trade margins at 70 per cent at the worth to Distributor (PTD) level earlier this month.
The NPPA, in an office memorandum on July 14, 2021, had directed manufacturers and importers of pulse oximeter, vital sign monitoring machine, nebuliser, digital thermometer and glucometer, to submit the revised MRPs of their products following the rationalisation of trade margin it imposed.
The prices of 156 pulse oximeter products, 216 vital sign monitoring devices, 137 nebulisers, 88 digital thermometers and 34 glucometers were submitted by the manufacturers and released by the NPPA on July 23.
The prices of pulse oximeter, after the trade margin rationalisation, stand between Rs. 489 to Rs. 60,000 a unit.
Prices of a number of the products have come down from over Rs. 4,000 per unit to around Rs. 1,000 a unit.
Blood pressure monitor prices range from Rs. 470 to around Rs. 1,65,850 a unit, consistent with the list released by the Authority.
The State Drug Controllers of all State and Union Territory governments shall monitor availability of those medical devices at the notified prices.
Any instances of hoarding, black-marketing and over pricing shall be viewed seriously and an appropriate action could also be initiated by the State Drug Controller concerned under the Essential Commodities Act, 1955, under intimation of the NPPA, it added
About NPPA :
The National Pharmaceutical Pricing Authority may be a government regulatory authority that controls the costs of pharmaceutical drugs in India.
Website: nppaindia.nic.in
Founded: 29 August 1997
Jurisdiction: India
Headquarters: New Delhi
Agency executive: Shubhra Singh (Chairperson)
Parent agency: Department of Pharmaceuticals
The NPPA, in an office memorandum on July 14, 2021, had directed manufacturers and importers of pulse oximeter, vital sign monitoring machine, nebuliser, digital thermometer and glucometer, to submit the revised MRPs of their products following the rationalisation of trade margin it imposed.
The prices of 156 pulse oximeter products, 216 vital sign monitoring devices, 137 nebulisers, 88 digital thermometers and 34 glucometers were submitted by the manufacturers and released by the NPPA on July 23.
The prices of pulse oximeter, after the trade margin rationalisation, stand between Rs. 489 to Rs. 60,000 a unit.
Prices of a number of the products have come down from over Rs. 4,000 per unit to around Rs. 1,000 a unit.
Blood pressure monitor prices range from Rs. 470 to around Rs. 1,65,850 a unit, consistent with the list released by the Authority.
The State Drug Controllers of all State and Union Territory governments shall monitor availability of those medical devices at the notified prices.
Any instances of hoarding, black-marketing and over pricing shall be viewed seriously and an appropriate action could also be initiated by the State Drug Controller concerned under the Essential Commodities Act, 1955, under intimation of the NPPA, it added
About NPPA :
The National Pharmaceutical Pricing Authority may be a government regulatory authority that controls the costs of pharmaceutical drugs in India.
Website: nppaindia.nic.in
Founded: 29 August 1997
Jurisdiction: India
Headquarters: New Delhi
Agency executive: Shubhra Singh (Chairperson)
Parent agency: Department of Pharmaceuticals